MEDOVEX CORP. (NASDAQ:MDVX) Files An 8-K Entry into a Material Definitive Agreement
Item 1.01 Entry into a Material Definitive Agreement.
On December 21, 2018, Medovex Corp. (the “Company”) entered into a Second Amended Warrant Agreement (the “Amended Warrant Agreement”) with Issuer Direct Corporation, fka Interwest Transfer Co., (the “Warrant Agent”). The Company and the Warrant Agent entered into the original Warrant Agreement on December 24, 2014 in connection with the Company’s initial public offering of its units (the “Original Warrant Agreement”) and entered into the first Amended Warrant Agency Agreement on February 4, 2016. The Warrant Agreement, as amended, set forth the terms of the warrants (the “Warrants”) included in the Company’s units and appointed the Warrant Agent to act as warrant agent for the Warrants.
The Company and the Warrant Agent entered into the Second Amended Warrant Agreement in order to amend 3.2 of the Warrant Agreement, as amended, to change the Expiration Date from December 24, 2018 to December 24, 2019.
The foregoing description of the Second Amended Warrant Agreement is qualified in its entirety by reference to the Second Amended Warrant Agreement, a copy of which is attached hereto as Exhibit 4.1 and is hereby incorporated by reference into this Item 1.01.
Item 3.03 Material Modification to Right of Security Holders
As set forth in Item 1.01 above, the Company amended the forms of their publicly traded Warrants to increase the duration of the Warrants for one year until December 24, 2019.
Item 9.01 Financial Statements and Exhibits
Medovex Corp. Exhibit
EX-4.1 2 ex4-1.htm EXHIBIT 4.1 SECOND AMENDED WARRANT AGENCY AGREEMENT This Agreement is made and entered into as of this 21st day of December,…
To view the full exhibit click